MedPage Today (1/11, Putka ) reports that many patients receiving “extracorporeal membrane oxygenation (ECMO)…experienced long-term neuropsychiatric symptoms, cognitive impairment, or functional impairment, a meta-analysis found.” The data indicated that “fully 41% of…patients” receiving ECMO “had neuropsychiatricsymptoms at 6 months or longer follow-up, with pain or discomfort (52%), sleep disturbance (37%), and anxiety (36%) as the most common symptoms.” Meanwhile, “long-term follow-up at 6 months and beyond also showed the secondary outcomes of neurocognitive impairment in 38% and functional impairment in 52%.” The findings were published in Neurology.
Related Links:
— MedPage Today (requires login and subscription)